SlideShare a Scribd company logo

Spotlight Webinar: GRADE

GRADE: appraising the quality of evidence and strength of recommendations The GRADE framework (Grading of Recommendations Assessment, Development and Evaluation) applies a rating of quality (i.e. confidence, certainty) of evidence and a grading of strength of recommendations for systematic reviews and clinical practice guidelines. The GRADE system classifies the quality of evidence and gives an overall rating of very low quality of evidence, low quality of evidence, moderate quality of evidence or high quality of evidence. The quality of evidence rating depends on a summary of many different factors. How can GRADE help you? The GRADE approach is useful when answering questions about interventions and when evidence-informed decision making is needed and recommendations are being produced. Originally developed for clinical interventions, the GRADE approach is designed to assess the quality of evidence for both randomized controlled trials and observational studies. A standard appraisal tool can be used to determine the risk of bias present in individual studies gathered from a systematic review, however GRADE addresses the quality of a body of evidence rather than individual studies. Click here to access the GRADE tool: http://www.nccmt.ca/knowledge-repositories/search/304 The National Collaborating Centre for Methods and Tools is funded by the Public Health Agency of Canada and affiliated with McMaster University. The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada. NCCMT is one of six National Collaborating Centres (NCCs) for Public Health. The Centres promote and improve the use of scientific research and other knowledge to strengthen public health practices and policies in Canada.

1 of 63
Download to read offline
Follow us @nccmt Suivez-nous @ccnmo
GRADE
(Grading of Recommendations Assessment, Development and Evaluation)
Presenters:
Gordon Guyatt, MD, MSc, FRCP, OC
Sarah McDowell, PhD
March 22, 2018 1:00 - 2:30 PM EST
Follow us @nccmt Suivez-nous @ccnmo
2
Housekeeping
Use Chat to post comments and/or
questions during the webinar
• ‘Send’ questions to All (not
privately to ‘Host’)
Connection issues
• Recommend using a wired
Internet connection (vs.
wireless),
• WebEx 24/7 help line
• 1-866-229-3239
Participant Side
Panel in WebEx
Chat
Follow us @nccmt Suivez-nous @ccnmo
3
After Today
The PowerPoint presentation (in English and
French) and English audio recording will be made
available.
These resources will be available at:
http://www.nccmt.ca/previous-webinars
Follow us @nccmt Suivez-nous @ccnmo
4
How many people are watching
today’s session with you?
Poll Question #1
A. Just me
B. 1-3
C. 4-5
D. 6-10
E. >10
Follow us @nccmt Suivez-nous @ccnmo
5
GRADE:
Appraising the quality of
evidence and strength of
recommendations
http://www.nccmt.ca/knowledge-repositories/search/304
NCC
Infectious
Diseases
Winnipeg, MB NCC
Methods
and Tools
Hamilton, ON
NCC Healthy
Public Policy
Montreal, QC
NCC
Determinants
of Health
Antigonish, NS
NCC
Aboriginal
Health
Prince George, BC
NCC
Environmental
Health
Vancouver, BC
6
Ad

Recommended

Declaration of-helsinki presantation
Declaration of-helsinki presantationDeclaration of-helsinki presantation
Declaration of-helsinki presantationManoharReddy183
 
Declaration Of Helsinki
Declaration Of HelsinkiDeclaration Of Helsinki
Declaration Of HelsinkiPradeep H
 
Medical research and study design
Medical research and study designMedical research and study design
Medical research and study designNaveen Phuyal
 
Bias, confounding and fallacies in epidemiology
Bias, confounding and fallacies in epidemiologyBias, confounding and fallacies in epidemiology
Bias, confounding and fallacies in epidemiologyTauseef Jawaid
 
Declaration of helsinki powerpoint presentation
Declaration of helsinki powerpoint presentationDeclaration of helsinki powerpoint presentation
Declaration of helsinki powerpoint presentationPoojaGupta767
 
Blinding in RCT the enigma unraveled
Blinding in RCT the enigma unraveledBlinding in RCT the enigma unraveled
Blinding in RCT the enigma unraveledMANVEER SINGH
 
Nuclear medicine-طراحي بخش پزشكي هسته اي
Nuclear medicine-طراحي بخش پزشكي هسته ايNuclear medicine-طراحي بخش پزشكي هسته اي
Nuclear medicine-طراحي بخش پزشكي هسته ايVahid Rahmani
 

More Related Content

What's hot

Radiation Protection Course For Orthopedic Specialists Lecture 2 of 4 Radiati...
Radiation Protection Course For Orthopedic Specialists Lecture 2 of 4 Radiati...Radiation Protection Course For Orthopedic Specialists Lecture 2 of 4 Radiati...
Radiation Protection Course For Orthopedic Specialists Lecture 2 of 4 Radiati...Amin Amin
 
Doses and Risks in Diagnostic Radiology, Interventional Radiology and Cardiol...
Doses and Risks in Diagnostic Radiology, Interventional Radiology and Cardiol...Doses and Risks in Diagnostic Radiology, Interventional Radiology and Cardiol...
Doses and Risks in Diagnostic Radiology, Interventional Radiology and Cardiol...DrAyush Garg
 
Non inferiority trials: any advantage for patients?
Non inferiority trials: any advantage for patients?Non inferiority trials: any advantage for patients?
Non inferiority trials: any advantage for patients?Cochrane.Collaboration
 
Ethics presentation
Ethics presentationEthics presentation
Ethics presentationEric Strayer
 
ETHICAL ISSUES IN BIOMEDICAL RESEARCH
ETHICAL ISSUES IN BIOMEDICAL RESEARCHETHICAL ISSUES IN BIOMEDICAL RESEARCH
ETHICAL ISSUES IN BIOMEDICAL RESEARCHHealth Forager
 
Causation in epidemiology
Causation in epidemiologyCausation in epidemiology
Causation in epidemiologyMehwish Iqbal
 
Occupational radiation safety in Nuclear Medicine
Occupational radiation safety in Nuclear MedicineOccupational radiation safety in Nuclear Medicine
Occupational radiation safety in Nuclear Medicineohscmcvellore
 
Cross sectional study
Cross sectional studyCross sectional study
Cross sectional studyAdugnagirma
 
Practical Aspect of Tc 99m radiopharmaceuticals
Practical Aspect of Tc 99m radiopharmaceuticalsPractical Aspect of Tc 99m radiopharmaceuticals
Practical Aspect of Tc 99m radiopharmaceuticals@Saudi_nmc
 
Translational research
Translational researchTranslational research
Translational researchShahin Hameed
 
Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015
Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015
Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015KCR
 
Statistics basics for oncologist kiran
Statistics basics for oncologist kiranStatistics basics for oncologist kiran
Statistics basics for oncologist kiranKiran Ramakrishna
 
Research Ethics Committees (RECs- IRBs)
Research Ethics Committees (RECs- IRBs)Research Ethics Committees (RECs- IRBs)
Research Ethics Committees (RECs- IRBs)Tamer Hifnawy
 
Benefits & Risks in Research Involving Human Particpants
Benefits & Risks in Research Involving Human ParticpantsBenefits & Risks in Research Involving Human Particpants
Benefits & Risks in Research Involving Human ParticpantsDr Ghaiath Hussein
 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...RAHUL PAL
 
Radiation and Medical Imaging
Radiation and Medical ImagingRadiation and Medical Imaging
Radiation and Medical ImagingBhavin Jankharia
 
Metal artifact reduction
Metal artifact reductionMetal artifact reduction
Metal artifact reductionwouterveldkamp
 

What's hot (20)

Radiation Protection Course For Orthopedic Specialists Lecture 2 of 4 Radiati...
Radiation Protection Course For Orthopedic Specialists Lecture 2 of 4 Radiati...Radiation Protection Course For Orthopedic Specialists Lecture 2 of 4 Radiati...
Radiation Protection Course For Orthopedic Specialists Lecture 2 of 4 Radiati...
 
Doses and Risks in Diagnostic Radiology, Interventional Radiology and Cardiol...
Doses and Risks in Diagnostic Radiology, Interventional Radiology and Cardiol...Doses and Risks in Diagnostic Radiology, Interventional Radiology and Cardiol...
Doses and Risks in Diagnostic Radiology, Interventional Radiology and Cardiol...
 
randomised control trial
randomised control trialrandomised control trial
randomised control trial
 
Non inferiority trials: any advantage for patients?
Non inferiority trials: any advantage for patients?Non inferiority trials: any advantage for patients?
Non inferiority trials: any advantage for patients?
 
Ethics presentation
Ethics presentationEthics presentation
Ethics presentation
 
Medical research
Medical researchMedical research
Medical research
 
ETHICAL ISSUES IN BIOMEDICAL RESEARCH
ETHICAL ISSUES IN BIOMEDICAL RESEARCHETHICAL ISSUES IN BIOMEDICAL RESEARCH
ETHICAL ISSUES IN BIOMEDICAL RESEARCH
 
Causation in epidemiology
Causation in epidemiologyCausation in epidemiology
Causation in epidemiology
 
Occupational radiation safety in Nuclear Medicine
Occupational radiation safety in Nuclear MedicineOccupational radiation safety in Nuclear Medicine
Occupational radiation safety in Nuclear Medicine
 
Cross sectional study
Cross sectional studyCross sectional study
Cross sectional study
 
Practical Aspect of Tc 99m radiopharmaceuticals
Practical Aspect of Tc 99m radiopharmaceuticalsPractical Aspect of Tc 99m radiopharmaceuticals
Practical Aspect of Tc 99m radiopharmaceuticals
 
Translational research
Translational researchTranslational research
Translational research
 
Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015
Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015
Safety Monitoring and Reporting in Clinical Trials DIA Poster 2015
 
Medical research
Medical researchMedical research
Medical research
 
Statistics basics for oncologist kiran
Statistics basics for oncologist kiranStatistics basics for oncologist kiran
Statistics basics for oncologist kiran
 
Research Ethics Committees (RECs- IRBs)
Research Ethics Committees (RECs- IRBs)Research Ethics Committees (RECs- IRBs)
Research Ethics Committees (RECs- IRBs)
 
Benefits & Risks in Research Involving Human Particpants
Benefits & Risks in Research Involving Human ParticpantsBenefits & Risks in Research Involving Human Particpants
Benefits & Risks in Research Involving Human Particpants
 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
 
Radiation and Medical Imaging
Radiation and Medical ImagingRadiation and Medical Imaging
Radiation and Medical Imaging
 
Metal artifact reduction
Metal artifact reductionMetal artifact reduction
Metal artifact reduction
 

Similar to Spotlight Webinar: GRADE

Patterns of adoption and use of a web-based decision support system for CVD r...
Patterns of adoption and use of a web-based decision support system for CVD r...Patterns of adoption and use of a web-based decision support system for CVD r...
Patterns of adoption and use of a web-based decision support system for CVD r...Health Informatics New Zealand
 
Making Healthcare Waste Reduction and Patient Safety Actionable - HAS Session 6
Making Healthcare Waste Reduction and Patient Safety Actionable - HAS Session 6Making Healthcare Waste Reduction and Patient Safety Actionable - HAS Session 6
Making Healthcare Waste Reduction and Patient Safety Actionable - HAS Session 6Health Catalyst
 
Technology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic AnalysesTechnology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic Analysesevadew1
 
Utility of primary care-based TIA electronic decision support
Utility of primary care-based TIA electronic decision supportUtility of primary care-based TIA electronic decision support
Utility of primary care-based TIA electronic decision supportHealth Informatics New Zealand
 
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016evadew1
 
K7 - Critical Appraisal.pdf
K7 - Critical Appraisal.pdfK7 - Critical Appraisal.pdf
K7 - Critical Appraisal.pdfJeslynTengkawan1
 
Bariatric surgery and copra ossicon 2016 presentation
Bariatric surgery and copra ossicon 2016 presentationBariatric surgery and copra ossicon 2016 presentation
Bariatric surgery and copra ossicon 2016 presentationAbhishek Katakwar
 
UKADC System Partners Meeting
UKADC System Partners MeetingUKADC System Partners Meeting
UKADC System Partners MeetingScott Buckler
 
How Allina Health Uses Analytics to Transform Care - HAS Session 16
How Allina Health Uses Analytics to Transform Care - HAS Session 16How Allina Health Uses Analytics to Transform Care - HAS Session 16
How Allina Health Uses Analytics to Transform Care - HAS Session 16Health Catalyst
 
Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?
Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?
Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?Office of Health Economics
 
Standard of Care - Donna Beardsworth
Standard of Care - Donna BeardsworthStandard of Care - Donna Beardsworth
Standard of Care - Donna BeardsworthTTC, llc
 
Asra defining value may 2015
Asra defining value may 2015Asra defining value may 2015
Asra defining value may 2015Colin McCartney
 
YCN Breast Educational Meeting 2015-NICE Breast Cancer Quality Standards- E A...
YCN Breast Educational Meeting 2015-NICE Breast Cancer Quality Standards- E A...YCN Breast Educational Meeting 2015-NICE Breast Cancer Quality Standards- E A...
YCN Breast Educational Meeting 2015-NICE Breast Cancer Quality Standards- E A...Jay Naik
 

Similar to Spotlight Webinar: GRADE (20)

Guidelines.pptx
Guidelines.pptxGuidelines.pptx
Guidelines.pptx
 
Patterns of adoption and use of a web-based decision support system for CVD r...
Patterns of adoption and use of a web-based decision support system for CVD r...Patterns of adoption and use of a web-based decision support system for CVD r...
Patterns of adoption and use of a web-based decision support system for CVD r...
 
Making Healthcare Waste Reduction and Patient Safety Actionable - HAS Session 6
Making Healthcare Waste Reduction and Patient Safety Actionable - HAS Session 6Making Healthcare Waste Reduction and Patient Safety Actionable - HAS Session 6
Making Healthcare Waste Reduction and Patient Safety Actionable - HAS Session 6
 
Technology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic AnalysesTechnology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic Analyses
 
Utility of primary care-based TIA electronic decision support
Utility of primary care-based TIA electronic decision supportUtility of primary care-based TIA electronic decision support
Utility of primary care-based TIA electronic decision support
 
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
 
Can Personalized Medicine Save the Health Care System?
Can Personalized Medicine Save the Health Care System?Can Personalized Medicine Save the Health Care System?
Can Personalized Medicine Save the Health Care System?
 
K7 - Critical Appraisal.pdf
K7 - Critical Appraisal.pdfK7 - Critical Appraisal.pdf
K7 - Critical Appraisal.pdf
 
EPR-delivered CPOE adoption rates predict reduced LOS
EPR-delivered CPOE adoption rates predict reduced LOSEPR-delivered CPOE adoption rates predict reduced LOS
EPR-delivered CPOE adoption rates predict reduced LOS
 
Bariatric surgery and copra ossicon 2016 presentation
Bariatric surgery and copra ossicon 2016 presentationBariatric surgery and copra ossicon 2016 presentation
Bariatric surgery and copra ossicon 2016 presentation
 
UKADC System Partners Meeting
UKADC System Partners MeetingUKADC System Partners Meeting
UKADC System Partners Meeting
 
How Allina Health Uses Analytics to Transform Care - HAS Session 16
How Allina Health Uses Analytics to Transform Care - HAS Session 16How Allina Health Uses Analytics to Transform Care - HAS Session 16
How Allina Health Uses Analytics to Transform Care - HAS Session 16
 
Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?
Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?
Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?
 
Quality in ICU
Quality in ICUQuality in ICU
Quality in ICU
 
Quality in icu
Quality in icuQuality in icu
Quality in icu
 
Standard of Care - Donna Beardsworth
Standard of Care - Donna BeardsworthStandard of Care - Donna Beardsworth
Standard of Care - Donna Beardsworth
 
Improving the Value of High-End Imaging
Improving the Value of High-End ImagingImproving the Value of High-End Imaging
Improving the Value of High-End Imaging
 
Cgix december investor-presentation
Cgix december investor-presentationCgix december investor-presentation
Cgix december investor-presentation
 
Asra defining value may 2015
Asra defining value may 2015Asra defining value may 2015
Asra defining value may 2015
 
YCN Breast Educational Meeting 2015-NICE Breast Cancer Quality Standards- E A...
YCN Breast Educational Meeting 2015-NICE Breast Cancer Quality Standards- E A...YCN Breast Educational Meeting 2015-NICE Breast Cancer Quality Standards- E A...
YCN Breast Educational Meeting 2015-NICE Breast Cancer Quality Standards- E A...
 

More from The National Collaborating Centre for Methods and Tools

More from The National Collaborating Centre for Methods and Tools (20)

TOUTES les données probantes : évaluer et utiliser des données probantes au s...
TOUTES les données probantes : évaluer et utiliser des données probantes au s...TOUTES les données probantes : évaluer et utiliser des données probantes au s...
TOUTES les données probantes : évaluer et utiliser des données probantes au s...
 
ALL the evidence webinar: Appraising and using evidence about community conte...
ALL the evidence webinar: Appraising and using evidence about community conte...ALL the evidence webinar: Appraising and using evidence about community conte...
ALL the evidence webinar: Appraising and using evidence about community conte...
 
Pleins feux sur les étudiants : des ressources pour vous préparer à une carri...
Pleins feux sur les étudiants : des ressources pour vous préparer à une carri...Pleins feux sur les étudiants : des ressources pour vous préparer à une carri...
Pleins feux sur les étudiants : des ressources pour vous préparer à une carri...
 
Focus on Students: Resources to Prepare you for your Public Health Career (2023)
Focus on Students: Resources to Prepare you for your Public Health Career (2023)Focus on Students: Resources to Prepare you for your Public Health Career (2023)
Focus on Students: Resources to Prepare you for your Public Health Career (2023)
 
Les réflexions des lauréates 2023 des Bourses d’application des connaissances...
Les réflexions des lauréates 2023 des Bourses d’application des connaissances...Les réflexions des lauréates 2023 des Bourses d’application des connaissances...
Les réflexions des lauréates 2023 des Bourses d’application des connaissances...
 
Insights from the 2023 Knowledge Translation Student Award Recipients
Insights from the 2023 Knowledge Translation Student Award RecipientsInsights from the 2023 Knowledge Translation Student Award Recipients
Insights from the 2023 Knowledge Translation Student Award Recipients
 
« Pleins feux » : un guide de communication de crise dans les médias sociaux
« Pleins feux » : un guide de communication de crise dans les médias sociaux « Pleins feux » : un guide de communication de crise dans les médias sociaux
« Pleins feux » : un guide de communication de crise dans les médias sociaux
 
Spotlight Webinar: A Guidebook for Social Media Crisis Communication
Spotlight Webinar: A Guidebook for Social Media Crisis CommunicationSpotlight Webinar: A Guidebook for Social Media Crisis Communication
Spotlight Webinar: A Guidebook for Social Media Crisis Communication
 
Le rôle de la santé publique auprès des refuges offrant des services aux pers...
Le rôle de la santé publique auprès des refuges offrant des services aux pers...Le rôle de la santé publique auprès des refuges offrant des services aux pers...
Le rôle de la santé publique auprès des refuges offrant des services aux pers...
 
The role of public health working with shelters serving people experiencing h...
The role of public health working with shelters serving people experiencing h...The role of public health working with shelters serving people experiencing h...
The role of public health working with shelters serving people experiencing h...
 
Appliquer des ressources axées sur l’action pour réduire les difficultés fina...
Appliquer des ressources axées sur l’action pour réduire les difficultés fina...Appliquer des ressources axées sur l’action pour réduire les difficultés fina...
Appliquer des ressources axées sur l’action pour réduire les difficultés fina...
 
Applying Action-Oriented Resources to Reduce Financial Strain and Promote Fin...
Applying Action-Oriented Resources to Reduce Financial Strain and Promote Fin...Applying Action-Oriented Resources to Reduce Financial Strain and Promote Fin...
Applying Action-Oriented Resources to Reduce Financial Strain and Promote Fin...
 
Outil de mesure des compétences en matière de prise de décision éclairée par ...
Outil de mesure des compétences en matière de prise de décision éclairée par ...Outil de mesure des compétences en matière de prise de décision éclairée par ...
Outil de mesure des compétences en matière de prise de décision éclairée par ...
 
Spotlight Webinar: Evidence Informed Decision Making (EIDM) Competence Measure
Spotlight Webinar: Evidence Informed Decision Making (EIDM) Competence MeasureSpotlight Webinar: Evidence Informed Decision Making (EIDM) Competence Measure
Spotlight Webinar: Evidence Informed Decision Making (EIDM) Competence Measure
 
Pleins feux sur les étudiants : des ressources pour vous préparer à une carri...
Pleins feux sur les étudiants : des ressources pour vous préparer à une carri...Pleins feux sur les étudiants : des ressources pour vous préparer à une carri...
Pleins feux sur les étudiants : des ressources pour vous préparer à une carri...
 
Focus on Students: Resources to Prepare you for your Public Health Career (2022)
Focus on Students: Resources to Prepare you for your Public Health Career (2022)Focus on Students: Resources to Prepare you for your Public Health Career (2022)
Focus on Students: Resources to Prepare you for your Public Health Career (2022)
 
Insights from the 2022 Knowledge Translation Student Award Recipients
Insights from the 2022 Knowledge Translation Student Award RecipientsInsights from the 2022 Knowledge Translation Student Award Recipients
Insights from the 2022 Knowledge Translation Student Award Recipients
 
Les réflexions des lauréates 2022 des Bourses d’application des connaissances...
Les réflexions des lauréates 2022 des Bourses d’application des connaissances...Les réflexions des lauréates 2022 des Bourses d’application des connaissances...
Les réflexions des lauréates 2022 des Bourses d’application des connaissances...
 
Lignes directrices du Centre de toxicomanie et de santé mentale (CAMH) sur l’...
Lignes directrices du Centre de toxicomanie et de santé mentale (CAMH) sur l’...Lignes directrices du Centre de toxicomanie et de santé mentale (CAMH) sur l’...
Lignes directrices du Centre de toxicomanie et de santé mentale (CAMH) sur l’...
 
The Centre for Addiction and Mental Health (CAMH) Lower-Risk Nicotine Use Gui...
The Centre for Addiction and Mental Health (CAMH) Lower-Risk Nicotine Use Gui...The Centre for Addiction and Mental Health (CAMH) Lower-Risk Nicotine Use Gui...
The Centre for Addiction and Mental Health (CAMH) Lower-Risk Nicotine Use Gui...
 

Recently uploaded

Exit Essay - Save the Filipino Language by Renz Perez.docx
Exit Essay - Save the Filipino Language by Renz Perez.docxExit Essay - Save the Filipino Language by Renz Perez.docx
Exit Essay - Save the Filipino Language by Renz Perez.docxMYDA ANGELICA SUAN
 
UniSC Fraser Coast library self-guided tour
UniSC Fraser Coast library self-guided tourUniSC Fraser Coast library self-guided tour
UniSC Fraser Coast library self-guided tourUSC_Library
 
2.15.24 Making Whiteness -- Baldwin.pptx
2.15.24 Making Whiteness -- Baldwin.pptx2.15.24 Making Whiteness -- Baldwin.pptx
2.15.24 Making Whiteness -- Baldwin.pptxMaryPotorti1
 
EDL 290F Week 1 - Meet Me at the Start Line.pdf
EDL 290F Week 1 - Meet Me at the Start Line.pdfEDL 290F Week 1 - Meet Me at the Start Line.pdf
EDL 290F Week 1 - Meet Me at the Start Line.pdfElizabeth Walsh
 
50 ĐỀ THI THỬ TỐT NGHIỆP THPT TIẾNG ANH 2024 CÓ GIẢI CHI TIẾT - GIỚI HẠN KHO...
50 ĐỀ THI THỬ TỐT NGHIỆP THPT TIẾNG ANH 2024 CÓ GIẢI CHI TIẾT - GIỚI HẠN KHO...50 ĐỀ THI THỬ TỐT NGHIỆP THPT TIẾNG ANH 2024 CÓ GIẢI CHI TIẾT - GIỚI HẠN KHO...
50 ĐỀ THI THỬ TỐT NGHIỆP THPT TIẾNG ANH 2024 CÓ GIẢI CHI TIẾT - GIỚI HẠN KHO...Nguyen Thanh Tu Collection
 
UniSC Sunshine Coast library self-guided tour
UniSC Sunshine Coast library self-guided tourUniSC Sunshine Coast library self-guided tour
UniSC Sunshine Coast library self-guided tourUSC_Library
 
Chromatography-Gas chromatography-Principle
Chromatography-Gas chromatography-PrincipleChromatography-Gas chromatography-Principle
Chromatography-Gas chromatography-Principleblessipriyanka
 
Evaluation and management of patients with Dyspepsia.pptx
Evaluation and management of patients with Dyspepsia.pptxEvaluation and management of patients with Dyspepsia.pptx
Evaluation and management of patients with Dyspepsia.pptxgarvitnanecha
 
catch-up-friday-ARALING PNLIPUNAN SOCIAL JUSTICE AND HUMAN RIGHTS
catch-up-friday-ARALING PNLIPUNAN SOCIAL JUSTICE AND HUMAN RIGHTScatch-up-friday-ARALING PNLIPUNAN SOCIAL JUSTICE AND HUMAN RIGHTS
catch-up-friday-ARALING PNLIPUNAN SOCIAL JUSTICE AND HUMAN RIGHTSCarlaNicolas7
 
Overview of Databases and Data Modelling-1.pdf
Overview of Databases and Data Modelling-1.pdfOverview of Databases and Data Modelling-1.pdf
Overview of Databases and Data Modelling-1.pdfChristalin Nelson
 
D.pharmacy Pharmacology 4th unit notes.pdf
D.pharmacy Pharmacology 4th unit notes.pdfD.pharmacy Pharmacology 4th unit notes.pdf
D.pharmacy Pharmacology 4th unit notes.pdfSUMIT TIWARI
 
CONCEPTS OF ENVIRONMENT & ECOSYSTEM.pptx
CONCEPTS OF ENVIRONMENT & ECOSYSTEM.pptxCONCEPTS OF ENVIRONMENT & ECOSYSTEM.pptx
CONCEPTS OF ENVIRONMENT & ECOSYSTEM.pptxAnupkumar Sharma
 
LIPIDS UNIT ONE BIOMOLECULE PRESENTATION
LIPIDS UNIT ONE BIOMOLECULE PRESENTATIONLIPIDS UNIT ONE BIOMOLECULE PRESENTATION
LIPIDS UNIT ONE BIOMOLECULE PRESENTATIONSayali Powar
 
Practical Research 1: Qualitative Research and Its Importance in Daily Life.pptx
Practical Research 1: Qualitative Research and Its Importance in Daily Life.pptxPractical Research 1: Qualitative Research and Its Importance in Daily Life.pptx
Practical Research 1: Qualitative Research and Its Importance in Daily Life.pptxKatherine Villaluna
 
Grantseeking Solo- Securing Awards with Limited Staff PDF.pdf
Grantseeking Solo- Securing Awards with Limited Staff  PDF.pdfGrantseeking Solo- Securing Awards with Limited Staff  PDF.pdf
Grantseeking Solo- Securing Awards with Limited Staff PDF.pdfTechSoup
 
2.20.24 The March on Washington for Jobs and Freedom.pptx
2.20.24 The March on Washington for Jobs and Freedom.pptx2.20.24 The March on Washington for Jobs and Freedom.pptx
2.20.24 The March on Washington for Jobs and Freedom.pptxMaryPotorti1
 
Barrow Motor Ability Test - TEST, MEASUREMENT AND EVALUATION IN PHYSICAL EDUC...
Barrow Motor Ability Test - TEST, MEASUREMENT AND EVALUATION IN PHYSICAL EDUC...Barrow Motor Ability Test - TEST, MEASUREMENT AND EVALUATION IN PHYSICAL EDUC...
Barrow Motor Ability Test - TEST, MEASUREMENT AND EVALUATION IN PHYSICAL EDUC...Rabiya Husain
 
SOCIAL JUSTICE LESSON ON CATCH UP FRIDAY
SOCIAL JUSTICE LESSON ON CATCH UP FRIDAYSOCIAL JUSTICE LESSON ON CATCH UP FRIDAY
SOCIAL JUSTICE LESSON ON CATCH UP FRIDAYGloriaRamos83
 
2.15.24 The Birmingham Campaign and MLK.pptx
2.15.24 The Birmingham Campaign and MLK.pptx2.15.24 The Birmingham Campaign and MLK.pptx
2.15.24 The Birmingham Campaign and MLK.pptxMaryPotorti1
 

Recently uploaded (20)

Exit Essay - Save the Filipino Language by Renz Perez.docx
Exit Essay - Save the Filipino Language by Renz Perez.docxExit Essay - Save the Filipino Language by Renz Perez.docx
Exit Essay - Save the Filipino Language by Renz Perez.docx
 
UniSC Fraser Coast library self-guided tour
UniSC Fraser Coast library self-guided tourUniSC Fraser Coast library self-guided tour
UniSC Fraser Coast library self-guided tour
 
Caldecott Medal Book Winners and Media Used
Caldecott Medal Book Winners and Media UsedCaldecott Medal Book Winners and Media Used
Caldecott Medal Book Winners and Media Used
 
2.15.24 Making Whiteness -- Baldwin.pptx
2.15.24 Making Whiteness -- Baldwin.pptx2.15.24 Making Whiteness -- Baldwin.pptx
2.15.24 Making Whiteness -- Baldwin.pptx
 
EDL 290F Week 1 - Meet Me at the Start Line.pdf
EDL 290F Week 1 - Meet Me at the Start Line.pdfEDL 290F Week 1 - Meet Me at the Start Line.pdf
EDL 290F Week 1 - Meet Me at the Start Line.pdf
 
50 ĐỀ THI THỬ TỐT NGHIỆP THPT TIẾNG ANH 2024 CÓ GIẢI CHI TIẾT - GIỚI HẠN KHO...
50 ĐỀ THI THỬ TỐT NGHIỆP THPT TIẾNG ANH 2024 CÓ GIẢI CHI TIẾT - GIỚI HẠN KHO...50 ĐỀ THI THỬ TỐT NGHIỆP THPT TIẾNG ANH 2024 CÓ GIẢI CHI TIẾT - GIỚI HẠN KHO...
50 ĐỀ THI THỬ TỐT NGHIỆP THPT TIẾNG ANH 2024 CÓ GIẢI CHI TIẾT - GIỚI HẠN KHO...
 
UniSC Sunshine Coast library self-guided tour
UniSC Sunshine Coast library self-guided tourUniSC Sunshine Coast library self-guided tour
UniSC Sunshine Coast library self-guided tour
 
Chromatography-Gas chromatography-Principle
Chromatography-Gas chromatography-PrincipleChromatography-Gas chromatography-Principle
Chromatography-Gas chromatography-Principle
 
Evaluation and management of patients with Dyspepsia.pptx
Evaluation and management of patients with Dyspepsia.pptxEvaluation and management of patients with Dyspepsia.pptx
Evaluation and management of patients with Dyspepsia.pptx
 
catch-up-friday-ARALING PNLIPUNAN SOCIAL JUSTICE AND HUMAN RIGHTS
catch-up-friday-ARALING PNLIPUNAN SOCIAL JUSTICE AND HUMAN RIGHTScatch-up-friday-ARALING PNLIPUNAN SOCIAL JUSTICE AND HUMAN RIGHTS
catch-up-friday-ARALING PNLIPUNAN SOCIAL JUSTICE AND HUMAN RIGHTS
 
Overview of Databases and Data Modelling-1.pdf
Overview of Databases and Data Modelling-1.pdfOverview of Databases and Data Modelling-1.pdf
Overview of Databases and Data Modelling-1.pdf
 
D.pharmacy Pharmacology 4th unit notes.pdf
D.pharmacy Pharmacology 4th unit notes.pdfD.pharmacy Pharmacology 4th unit notes.pdf
D.pharmacy Pharmacology 4th unit notes.pdf
 
CONCEPTS OF ENVIRONMENT & ECOSYSTEM.pptx
CONCEPTS OF ENVIRONMENT & ECOSYSTEM.pptxCONCEPTS OF ENVIRONMENT & ECOSYSTEM.pptx
CONCEPTS OF ENVIRONMENT & ECOSYSTEM.pptx
 
LIPIDS UNIT ONE BIOMOLECULE PRESENTATION
LIPIDS UNIT ONE BIOMOLECULE PRESENTATIONLIPIDS UNIT ONE BIOMOLECULE PRESENTATION
LIPIDS UNIT ONE BIOMOLECULE PRESENTATION
 
Practical Research 1: Qualitative Research and Its Importance in Daily Life.pptx
Practical Research 1: Qualitative Research and Its Importance in Daily Life.pptxPractical Research 1: Qualitative Research and Its Importance in Daily Life.pptx
Practical Research 1: Qualitative Research and Its Importance in Daily Life.pptx
 
Grantseeking Solo- Securing Awards with Limited Staff PDF.pdf
Grantseeking Solo- Securing Awards with Limited Staff  PDF.pdfGrantseeking Solo- Securing Awards with Limited Staff  PDF.pdf
Grantseeking Solo- Securing Awards with Limited Staff PDF.pdf
 
2.20.24 The March on Washington for Jobs and Freedom.pptx
2.20.24 The March on Washington for Jobs and Freedom.pptx2.20.24 The March on Washington for Jobs and Freedom.pptx
2.20.24 The March on Washington for Jobs and Freedom.pptx
 
Barrow Motor Ability Test - TEST, MEASUREMENT AND EVALUATION IN PHYSICAL EDUC...
Barrow Motor Ability Test - TEST, MEASUREMENT AND EVALUATION IN PHYSICAL EDUC...Barrow Motor Ability Test - TEST, MEASUREMENT AND EVALUATION IN PHYSICAL EDUC...
Barrow Motor Ability Test - TEST, MEASUREMENT AND EVALUATION IN PHYSICAL EDUC...
 
SOCIAL JUSTICE LESSON ON CATCH UP FRIDAY
SOCIAL JUSTICE LESSON ON CATCH UP FRIDAYSOCIAL JUSTICE LESSON ON CATCH UP FRIDAY
SOCIAL JUSTICE LESSON ON CATCH UP FRIDAY
 
2.15.24 The Birmingham Campaign and MLK.pptx
2.15.24 The Birmingham Campaign and MLK.pptx2.15.24 The Birmingham Campaign and MLK.pptx
2.15.24 The Birmingham Campaign and MLK.pptx
 

Spotlight Webinar: GRADE

  • 1. Follow us @nccmt Suivez-nous @ccnmo GRADE (Grading of Recommendations Assessment, Development and Evaluation) Presenters: Gordon Guyatt, MD, MSc, FRCP, OC Sarah McDowell, PhD March 22, 2018 1:00 - 2:30 PM EST
  • 2. Follow us @nccmt Suivez-nous @ccnmo 2 Housekeeping Use Chat to post comments and/or questions during the webinar • ‘Send’ questions to All (not privately to ‘Host’) Connection issues • Recommend using a wired Internet connection (vs. wireless), • WebEx 24/7 help line • 1-866-229-3239 Participant Side Panel in WebEx Chat
  • 3. Follow us @nccmt Suivez-nous @ccnmo 3 After Today The PowerPoint presentation (in English and French) and English audio recording will be made available. These resources will be available at: http://www.nccmt.ca/previous-webinars
  • 4. Follow us @nccmt Suivez-nous @ccnmo 4 How many people are watching today’s session with you? Poll Question #1 A. Just me B. 1-3 C. 4-5 D. 6-10 E. >10
  • 5. Follow us @nccmt Suivez-nous @ccnmo 5 GRADE: Appraising the quality of evidence and strength of recommendations http://www.nccmt.ca/knowledge-repositories/search/304
  • 6. NCC Infectious Diseases Winnipeg, MB NCC Methods and Tools Hamilton, ON NCC Healthy Public Policy Montreal, QC NCC Determinants of Health Antigonish, NS NCC Aboriginal Health Prince George, BC NCC Environmental Health Vancouver, BC 6
  • 7. Registry of Methods and Tools Online Learning Opportunities WorkshopsMultimedia Public Health+ Networking and Outreach NCCMT Products and Services 7
  • 8. Follow us @nccmt Suivez-nous @ccnmo 8 Poll Question #2 How familiar are you with the method or tool we are discussing today? A. I am not familiar with the method or tool B. I have heard of the method or tool C. I have used the method or tool
  • 9. Follow us @nccmt Suivez-nous @ccnmo 9 Presenters Gordon Guyatt, MD, MSc, FRCP, OC Distinguished Professor, Department of Health Research Methods, Evidence, and Impact, McMaster University Sarah McDowell, PhD Manager, Clinical Reviews, Health Quality Ontario
  • 11.  GRADE background  Two steps  confidence in estimates  strength of recommendation  Evidence profiles
  • 12.  Group started to meet in 2000  First paper describing method BMJ 2004  Guidance for clinicians to understand GRADE  six part series in BMJ 20008  For systematic review, guideline developers  17 part series, 2011 to 2017, J Clinical Epidemiology  2 chapters in Cochrane Handbook
  • 13. >100 organizations have adopted GRADE
  • 15.  RCTs start high  Observational studies start low  5 limitations can lower quality  Risk of bias  Inconsistency  Indirectness  Imprecision  Publication bias
  • 16.  Well established  concealment  intention to treat principle observed  blinding  completeness of follow-up  More recent  selective outcome reporting bias  early stopping for benefit
  • 17.  Small sample size  small number of events  Wide confidence intervals  uncertainty about magnitude of effect  How do you decide what is too wide?  Primary criterion:  would decisions differ at ends of CI
  • 18. 01.0%
  • 19.  Variation in size of effect  Overlap in confidence intervals  statistical significance of heterogeneity  I2
  • 21. Learning Programs to Accelerate the BioPharma Transition Relative Risk with 95% CI for Vitamin D Non-vertebral Fractures Chapuy et al, (2002) 0.85 (0.64, 1.13) Pooled Random Effect Model 0.82 (0.69 to 0.98) p= 0.05 for heterogeneity, I2=53% Chapuy et al, (1994) 0.79 (0.69, 0.92) Lips et al, (1996) 1.10 (0.87, 1.39) Dawson-Hughes et al, (1997) 0.46 (0.24, 0.88) Pfeifer et al, (2000) 0.48 (0.13, 1.78) Meyer et al, (2002) 0.92 (0.68, 1.24) Trivedi et al, (2003) 0.67 (0.46, 0.99) Favors Vitamin D Favors Control Relative Risk 95% CI ' ' ' ' ' ' ' ' 0.1 1
  • 22. Explanations of heterogeneity: Where to look?  Patients  Interventions  Outcomes  Methodology
  • 23. Relative Risk with 95% CI for Vitamin D (Non-Vertebral Fractures, Dose >400)
  • 24. Relative Risk with 95% CI for Vitamin D (Non-Vertebral Fractures, Dose = 400)
  • 25.  Populations  older, sicker or more co-morbidity  Interventions  warfarin in trials vs clinical practice  Outcomes  important versus surrogate outcomes  glucose control versus CV events
  • 26. Alendronate Risedronate Placebo Directness interested in A versus B available data A vs C, B vs C
  • 27.  High likelihood could lower quality  When to suspect ▪ number of small studies ▪ industry sponsored
  • 29.  Large magnitude can rate up one level  very large two levels  Common criteria  everyone used to do badly  almost everyone does well  quick action  Hip replacement for hip osteoarthritis
  • 30. Certainty assessment criteria Study Design Confidence in estimates Lower if Higher if Randomized trials High Risk of bias -1 Serious -2Very serious Inconsistency -1 Serious -2Very serious Indirectness -1 Serious -2Very serious Imprecision -1 Serious -2Very serious Publication bias -1 Likely -2Very likely Large Effect + 1 Large + 1Very large Dose response +1 Evidence of a gradient All plausible confounding +1 Would reduce a demonstrated effect or +1 would suggest a spurious effect when results show no effect Moderate Observational studies Low Very Low
  • 31.  Most systems just use evidence about primary benefit outcome  But what about others (harms)?  What to do?  Options  ignore all but primary  weakest of any outcome  some blended approach  weakest of critical outcomes
  • 32. Quality Assessment Summary of Findings Quality Relative Effect (95% CI) Absolute risk difference Outcome Number of participants (studies) Risk of Bias Consistency Directness Precision Publication Bias Myocardial infarction 10,125 (9) No serious limitations No serious imitations No serious limitations No serious limitations Not detected High 0.71 (0.57 to 0.86) 1.5% fewer (0.7% fewer to 2.1% fewer) Mortality 10,205 (7) No serious limitations No serious limiations No serious limitations Imprecise Not detected Moderate 1.23 (0.98 – 1.55) 0.5% more (0.1% fewer to 1.3% more) Stroke 10,889 (5) No serious limitaions No serious limitations No serious limitations Serious limitations Not detected Moderate 1.67 (1.00 – 2.80) 0.3% more (0 more to 1.5% more) Beta blockers in non-cardiac surgery
  • 33.  Strong recommendation  benefits clearly outweigh risks/hassle/cost  risk/hassle/cost clearly outweighs benefit  What can downgrade strength?  Low confidence in estimates  Close balance between up and downsides
  • 34.  Aspirin after myocardial infarction  25% reduction in relative risk  side effects minimal, cost minimal  benefit obviously much greater than risk/cost  Anticoagulants versus aspirin in low risk atrial fibrillation  anticoagulants reduces stroke vs ASA by 50%  but if risk only 1% per year, ARR 0.5%  increased bleeds by 1% per year
  • 35. Aspirin after MI – do it Warfarin rather than ASA in Afib -- probably do it -- probably don’t do it
  • 36.  Variability in patient preference  strong, almost all same choice (> 90%)  weak, choice varies appreciably  Interaction with patient  strong, just inform patient  weak, ensure choice reflects values  Use of decision aid  strong, don’t bother; weak, use the aid  Quality of care criterion  strong, consider; weak, don’t consider
  • 37.  Clinicians, policy makers need summaries  quality of evidence  strength of recommendations  Explicit rules  transparent, informative  GRADE  simple, transparent, systematic  increasing wide adoption
  • 38. GRADE: A User Perspective NCCMT Spotlight Webinar 22 March 2018 SARAH MCDOWELL HEALTH QUALITY ONTARIO
  • 39. 39 Outline • Overview of HQO and the Health Technology Assessment (HTA) Program • Three examples of how we have used GRADE in our HTAs
  • 40. 40 Health Technology Assessment at Health Quality Ontario • HQO has a legislated mandated to make recommendations to the Minister of Health on public funding for health care services and medical devices • The Ontario Health Technology Advisory Committee (OHTAC) reviews the HTA evidence and makes recommendations to HQO • Within the HTAs, we consider: – Clinical benefits and harms – Value for money and affordability – Patient preferences and values
  • 41. 41 Use of GRADE at Health Quality Ontario • Used within the clinical evidence component of the HTA • Have used GRADE since 2004 • OHTAC makes a yes/no recommendation, and does not GRADE the strength of the recommendations
  • 43. 43 Mechanical Thrombectomy for Patients With Acute Ischemic Stroke Research question • What are the clinical benefits and harms of endovascular treatment via new generation mechanical thrombectomy devices (with or without IVT) compared to IVT alone (if eligible) in patients with acute ischemic stroke caused by a proximal intracranial occlusion in the anterior circulation? Results • Systematic review identified 5 RCTs (ranged in size from 50 to 500 patients)
  • 44. 44 Mechanical Thrombectomy for Patients With Acute Ischemic Stroke Mortality Functional independence
  • 45. 45 Mechanical Thrombectomy for Patients With Acute Ischemic Stroke Outcome No. of participants (studies) Anticipated absolute effects (95% CI) Relative effect (95% CI) Certainty of the evidence (GRADE)Risk with IVT Risk difference with MT Functional independence N = 1278 (5 RCTs) 264 per 1,000 197 more per 1,000 (139 more to 258 more) OR: 2.39 (1.88 to 3.04) ⊕⊕⊕⊕ HIGH Mortality N = 1282 (5 RCTs) 188 per 1,000 32 fewer per 1,000 (66 fewer to 11 more) OR: 0.8 (0.6 to 1.07) ⊕⊕⊕ MODERATE due to imprecision Symptomatic intracerebral hemorrhage N = 1286 (5 RCTs) 43 per 1,000 4 more per 1,000 (14 fewer to 34 more) OR: 1.11 (0.66 to 1.87) ⊕⊕⊕ MODERATE due to imprecision MT = Mechanical thrombectomy; IVT = Intravenous thrombolysis
  • 46. 46 Mechanical Thrombectomy for Patients With Acute Ischemic Stroke Funding recommendation (February 2016) • “Health Quality Ontario, under the guidance of the Ontario Health Technology Advisory Committee, recommends publicly funding stent retrievers and thromboaspiration devices for mechanical thrombectomy in patients with acute ischemic stroke, in selected stroke centres identified by the Ontario Stroke Network.” http://www.hqontario.ca/portals/0/documents/evidence/reports/recommendation- mechanical-thrombectomy-1602-en.pdf
  • 47. 47 Electrical Stimulation for Pressure Injuries Research question • In adults with pressure injuries, what are the clinical benefits and harms of electrical stimulation plus standard wound care compared with standard wound care alone? Results • Systematic review identified 9 RCTs and 2 non- randomized controlled trials
  • 48. 48 Electrical Stimulation for Pressure Injuries Outcome No. of participants (studies) Results Certainty of the evidence (GRADE) Time to heal N = 97 (2 RCTs) No difference between healing times comparing Estim vs. standard wound care ⊕⊕ LOW due to risk of bias and imprecision Complications N = 236 (5 RCTs) 3/5 studies: minor events reported ⊕⊕⊕⊕ HIGH Relative rate of healing N = 211 (1 RCT, 2 NRCTs) 2/3 studies found significant difference comparing Estim vs. standard wound care ⊕⊕ LOW due to risk of bias and indirectness
  • 49. 49 Electrical Stimulation for Pressure Injuries Funding recommendation (November 2017) • “Health Quality Ontario, under the guidance of the Ontario Health Technology Advisory Committee, recommends against publicly funding electrical stimulation for pressure injuries” http://www.hqontario.ca/Portals/0/documents/evidence/reports/ohtac-recommendations- electrical-stimulation-1711-en.pdf
  • 50. 50 Retinal Prosthesis System for Advanced Retinitis Pigmentosa Research question • What are the clinical benefits and harms of the Argus II retinal prosthesis system when used to treat patients with bare to no light perception vision as a result of advanced retinitis pigmentosa? Results • Systematic review identified 1 prospective cohort study of 30 patients
  • 51. 51 Retinal Prosthesis System for Advanced Retinitis Pigmentosa Visual function Outcome No. of participants (studies) Results* Certainty of the evidence (GRADE) Object localization N = 30 (1 non-RCT) 1-year: 93.8% 3-year: 89.3% 5-year: 80.9% ⊕⊕⊕ MODERATE upgraded due to underlying trajectory of retinitis pigmentosa (+1) Direction of motion N = 30 (1 non-RCT) 1-year: 62.5% 3-year: 55.6% 5-year: 50.0% ⊕⊕⊕ MODERATE upgraded due to underlying trajectory of retinitis pigmentosa (+1) Grating visual acuity N = 30 (1 non-RCT) 1-year: 48.2% 3-year: 33.3% 5-year: 38.1% ⊕⊕⊕ MODERATE upgraded due to underlying trajectory of retinitis pigmentosa (+1) *Results were % patients performed significantly better (P<0.05) with Argus II on vs. off
  • 52. 52 Retinal Prosthesis System for Advanced Retinitis Pigmentosa Funding recommendation (November 2017) • “Health Quality Ontario, under the guidance of the Ontario Health Technology Advisory Committee recommends publicly funding the Argus II retinal prosthesis system for advanced retinitis pigmentosa” http://www.hqontario.ca/Portals/0/documents/evidence/reports/ohtac-recommendations- retinal-prosthesis-1711-en.pdf
  • 53. 53 General Advice and Reflections • Discuss the ratings with colleagues • Engage with clinicians to gain an understanding of the health care condition • GRADE summary of findings table is useful for conveying information • Follow GRADE working group
  • 54. 54 Summary • GRADE provides us with a structured, consistent approach to evaluate and present the quality of the body of the evidence • GRADE provides important information for decision- making about the certainty of the effectiveness of a treatment.
  • 55. 55 References HQO Evidence to Improve Care http://www.hqontario.ca/Evidence-to-Improve-Care Mechanical Thrombectomy in Patients With Acute Ischemic Stroke HTA: http://www.hqontario.ca/Portals/0/Documents/evidence/reports/hta-mechanical-thrombectomy-1602- en.pdf HQO recommendation: http://www.hqontario.ca/portals/0/documents/evidence/reports/recommendation- mechanical-thrombectomy-1602-en.pdf Retinal Prosthesis System for Advanced Retinitis Pigmentosa HTA: http://www.hqontario.ca/Portals/0/documents/evidence/reports/hta-retinal-prosthesis-1711.pdf HQO recommendation: http://www.hqontario.ca/Portals/0/documents/evidence/reports/ohtac- recommendations-retinal-prosthesis-1711-en.pdf Electrical Stimulation for Pressure Injuries HTA: http://www.hqontario.ca/Portals/0/documents/evidence/reports/hta-electrical-stimulation-1711.pdf HQO recommendation: http://www.hqontario.ca/Portals/0/documents/evidence/reports/ohtac- recommendations-electrical-stimulation-1711-en.pdf HQO HTA Process and Methods Guide: http://www.hqontario.ca/Portals/0/documents/evidence/reports/hta-methods-and-process-guide-en.pdf
  • 57. Follow us @nccmt Suivez-nous @ccnmo 57 Your Comments/Questions • Use Chat to post comments and/or questions • ‘Send’ questions to All (not privately to ‘Host’) Chat Participant Side Panel in WebEx
  • 58. Follow us @nccmt Suivez-nous @ccnmo 58 Poll Question #3 Could this method or tool be useful in practice? A. Very useful B. Somewhat useful C. Not at all useful D. Don’t know
  • 59. Follow us @nccmt Suivez-nous @ccnmo 59 Your Feedback is Important Please take a few minutes to share your thoughts on today’s webinar. Your comments and suggestions help to improve the resources we offer and plan future webinars. The short survey is available at: https://surveys.mcmaster.ca/limesurvey/index.php/ 163839?lang=en
  • 60. Follow us @nccmt Suivez-nous @ccnmo 60 Poll Question #4 What are your next steps? (Check all that apply) A. Access the method/tool referenced in the presentation B. Read the NCCMT summary about the method/tool described today C. Consider using the method/tool in practice D. Tell a colleague about the method/tool
  • 61. Follow us @nccmt Suivez-nous @ccnmo Share your story! • Are you using EIDM in your practice? We want to hear about it! • Email us: nccmt@mcmaster.ca • Need support for EIDM? Contact us for help! • Email us: nccmt@mcmaster.ca • We typically respond within 24 business hours 61
  • 62. Follow us @nccmt Suivez-nous @ccnmo Webinar Series from the NCCMT www.nccmt.ca/webinar-series • Spotlight on KT Methods and Tools • Topic-Specific Methods and Tools • Online Journal Club • Peer-to-peer Webinars 62
  • 63. Follow us @nccmt Suivez-nous @ccnmo Funded by the Public Health Agency of Canada | Affiliated with McMaster University Production of this presentation has been made possible through a financial contribution from the Public Health Agency of Canada. The views expressed here do not necessarily reflect the views of the Public Health Agency of Canada.. For more information about the National Collaborating Centre for Methods and Tools: NCCMT website www.nccmt.ca Contact: nccmt@mcmaster.ca